Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
CT-388 (red) sits on the 1:1 diagonal, indicating balanced engagement of both GLP-1R and GIPR (EC50 = 0.030 nM for both)
Treatment with GLP-1RAs can provide supraphysiologic and sustained stimulation of the GLP-1 receptor
Since GLP-1 agonists are effective in reducing appetite and promoting weight loss, they have become an increasingly common prescription for individuals who meet certain weight or health criteria, even if they do not have diabetes
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
How Long Do Patients Stay on Treatment
US$ 29.08
US$ 25.71
US$ 26.56
